StockData
Oncotelic Therapeutics, Inc. logo

Oncotelic Therapeutics, Inc. (OTLC) stock

OTLCOTCPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$0.02+0.00 (+11.45%)

Close on Oct 19, 2026Market cap $8.66MP/E 0.0Yield –

Oncotelic Therapeutics revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Oncotelic Therapeutics's revenue for the twelve months ending Dec 31, 2023 was $70.00K. For fiscal 2023 it was $70.00K, down 96.0% from the year before.

Annual revenue

PeriodPeriod endValueChange
FY2023Dec 31, 2023$70.00K-96.0%
FY2020Dec 31, 2020$1.74M+1732.5%
FY2013Dec 31, 2013$95.00K-39.1%
FY2012Dec 31, 2012$156.00K–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$250.00K–
Q4 FY2023Dec 31, 2023$0-100.0%
Q3 FY2023Sep 30, 2023$70.00K-79.5%
Q4 FY2020Dec 31, 2020$0–
Q3 FY2020Sep 30, 2020$0–
Q2 FY2020Jun 30, 2020$1.40M–
Q1 FY2020Mar 31, 2020$340.86K–

More Oncotelic Therapeutics figures

See a number that looks wrong?